The Role of Angiotensin Receptor Blockers in Patients with Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
- 22 March 2011
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 45 (4) , 520-524
Abstract
OBJECTIVE: To assess the safety of using angiotensin II receptor blockers (ARBs) in patients who develop angioedema with the use of angiotensin-converting enzyme inhibitors (ACEIs). DATA SOURCES: A literature search was performed using MEDLINE (1977-January 2011) and Cochrane Library, using the terms angiotensin receptor blocker, angiotensin-converting enzyme inhibitor, and angioedema. In addition, reference citations from publications identified were reviewed. STUDY SELECTION AND DATA EXTRACTION: Only English-language publications were included. Randomized controlled trial data, observational studies (retrospective and prospective), and case reports on adults who received ACEI therapy and then an ARB as an alternative therapy were reviewed. DATA SYNTHESIS: Two randomized controlled trials and 1 meta-analysis evaluated ARB use in patients intolerant to ACEIs. Taken together, there is a conservative estimate of a 10% or less incidence of cross reactivity of angioedema in patients who receive an ARB after experiencing ACEI-associated angioedema. Angioedema related to ARBs is reported to be less severe and occurs earlier compared to angioedema that develops during ACEI therapy. CONCLUSIONS: ARBs may be an alternative for patients who develop angioedema while using an ACEI but should be reserved for patients with high therapeutic need for angiotensin inhibition. Treatment should be started with observation, patients should be educated on the signs of angioedema, and proper emergency management should be emphasized to patients and care providers.Keywords
This publication has 16 references indexed in Scilit:
- USE OF ANGIOTENSIN RECEPTOR BLOCKERS AFTER ANGIOEDEMA WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITORAnnals of Allergy, Asthma & Immunology, 2009
- Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysisAnnals of Allergy, Asthma & Immunology, 2008
- Angiotensin-Converting Enzyme Inhibitors and AngioedemaHypertension, 2008
- 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial InfarctionCirculation, 2008
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation, 2007
- Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersAnnals of Allergy, Asthma & Immunology, 2007
- Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonistsThe American Journal of Medicine, 2005
- Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor UseArchives of internal medicine (1960), 2004
- Accupril- and Cozaar-induced angioedema in the same patientJournal of Allergy and Clinical Immunology, 1996
- Angiotensin Receptors and Their AntagonistsNew England Journal of Medicine, 1996